Real-ear measurement and fitting outcomes

The evidence supporting real-ear measurement (REM) as the standard of care for hearing aid fitting is extensive and consistent. Key findings:

• Fitting accuracy without REM: Multiple studies have demonstrated that hearing aids fitted without REM frequently deviate significantly from prescriptive targets. Aazh & Moore (2007) found that only 30–40% of hearing aids fitted without REM achieved targets within ±10 dB across frequencies. Valente & Oeding (2015) found similar results in a US clinical sample.
• Outcomes with REM vs. without: Patients whose hearing aids were verified with REM consistently show better speech understanding outcomes and higher satisfaction than those fitted without REM. Abrams et al. (2012) demonstrated significantly better APHAB scores in the REM-verified group.
• REM adoption rates: Despite the evidence, surveys consistently show that fewer than 30% of hearing aid fittings in the US include REM (Kochkin, 2011; Kirkwood, 2010). This represents a significant quality gap in clinical practice.
• Time and cost: REM adds approximately 15–20 minutes to a fitting appointment. Studies have not found that REM significantly increases the cost of care when the improved outcomes (reduced returns, higher satisfaction, fewer follow-up visits) are accounted for.

Hearing loss and cognitive decline

The relationship between hearing loss and cognitive decline — including dementia — has become one of the most clinically significant research areas in audiology. Key findings:

• Lancet Commission on Dementia (2020, updated 2024): The Lancet Commission identified hearing loss as the largest modifiable risk factor for dementia, accounting for approximately 8% of dementia cases globally. The 2024 update maintained hearing loss as the single largest modifiable risk factor.
• ACHIEVE trial (2023): The Aging and Cognitive Health Evaluation in Elders (ACHIEVE) randomized controlled trial — the largest RCT of hearing intervention and cognitive outcomes — found that hearing intervention (hearing aids plus audiologic counseling) slowed cognitive decline by 48% over 3 years in older adults at higher risk for cognitive decline. This was a landmark finding that significantly strengthened the case for early hearing aid adoption.
• Mechanisms: Proposed mechanisms linking hearing loss to cognitive decline include cognitive load (increased effort required for listening depletes cognitive resources), social isolation (hearing loss reduces social engagement, a known dementia risk factor), and shared pathology (common underlying vascular or neurodegenerative processes affecting both hearing and cognition).
• Clinical implications: The ACHIEVE findings provide a compelling evidence-based argument for early hearing aid adoption that goes beyond communication benefit. Audiologists should incorporate cognitive health messaging into counseling, particularly for older adults who are ambivalent about hearing aids.

OTC hearing aid outcomes research

Research on OTC hearing aid outcomes has grown rapidly since the FDA rule took effect in 2022. Key findings:

• Self-fitting accuracy: Studies comparing self-fitted OTC aids to audiologist-fitted prescription aids consistently show that professional fitting produces better audiometric outcomes. Humes et al. (2017) — a landmark pre-OTC-rule study — found that self-fitted aids provided meaningful benefit but that audiologist-fitted aids produced significantly better speech understanding outcomes.
• Patient satisfaction: Satisfaction with OTC aids is variable and correlates with degree of loss. Patients with milder losses report higher satisfaction; those with moderate losses are more likely to be dissatisfied with OTC performance.
• Access and adoption: OTC aids have meaningfully increased hearing aid adoption among previously untreated individuals, particularly in lower-income populations. This is a genuine public health benefit that audiologists should acknowledge.
• Safety: Post-market surveillance data through 2025 has not identified significant safety concerns with OTC hearing aids when used as directed. The FDA's output limits appear to be effective in preventing over-amplification.

AI and deep neural network processing

Research on AI-driven hearing aid processing is an active and rapidly evolving area. Key findings:

• Oticon DNN outcomes: Multiple studies on Oticon's deep neural network processing (More, Real, Intent platforms) have demonstrated improved speech understanding in complex listening environments compared to conventional processing. Signoret et al. (2020) found significantly better speech understanding in noise with DNN processing. Listening effort studies using pupillometry and EEG have shown reduced cognitive load with DNN processing.
• AI environment classification: AI-driven environment classification systems (Phonak AutoSense OS, Oticon MoreSound Intelligence) have been shown to select appropriate processing parameters more accurately than rule-based systems in complex, rapidly changing acoustic environments.
• Personalization: Machine learning approaches to hearing aid personalization (Widex SoundSense Learn, Starkey Thrive) show promise for improving individual satisfaction, though large-scale RCT evidence is still limited.

Hearing aid use and quality of life

• Consistent QoL benefit: Meta-analyses consistently demonstrate significant improvements in quality of life, communication function, and social participation with hearing aid use. Chisolm et al. (2007) — a systematic review of 12 RCTs — found strong evidence for QoL benefit across multiple outcome domains.
• Non-use rates: Despite demonstrated benefit, hearing aid non-use remains a significant clinical problem. Approximately 20–30% of hearing aids are not worn regularly. Non-use is associated with poor counseling, unrealistic expectations, poor fit, and inadequate follow-up.
• Bilateral vs. unilateral fitting: Bilateral fitting consistently produces better outcomes than unilateral fitting for patients with bilateral hearing loss. Improved sound localization, better speech understanding in noise, and higher satisfaction are consistently demonstrated. Unilateral fitting should be reserved for patients with significant asymmetric loss or specific medical contraindications.

Key journals and research resources

• Journal of the American Academy of Audiology (JAAA): The primary peer-reviewed journal of the AAA. Covers clinical research, technology, and practice management.
• Ear and Hearing: Published by the American Auditory Society. High-impact journal covering basic and clinical auditory research.
• International Journal of Audiology (IJA): International peer-reviewed journal covering audiology research across all subspecialties.
• Trends in Hearing: Open-access journal from SAGE Publishing covering hearing research and audiology.
• PubMed / MEDLINE: The primary database for audiology literature searches. Free access at pubmed.ncbi.nlm.nih.gov.
• National Acoustic Laboratories (NAL): The Australian NAL publishes extensive research on hearing aid fitting, prescriptive targets, and outcomes. Much of it is freely available at nal.gov.au.
• Ida Institute: Publishes research and clinical tools on person-centered care in audiology. Free resources at idainstitute.com.